[Clinical evaluation of Daonil--a new sulphonylurea derivative].
D000284:Administration, Oral; D000368:Aged; D003510:Cyclohexanes / Q000009:adverse effects / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D003510:Cyclohexanes; D007004:Hypoglycemic Agents
Ocena kliniczna "Daonilu" nowej pochodnej sulfonylomocznika.